Objectives To assess the prevalence of high on-clopidogrel platelet reactivity (HCPR) in
patients with ischaemic stroke or transient ischaemic attack (IS/TIA), their outcome and …

The elderly population is increasing worldwide, associated with an increase in diseases
related to aging, such as hip fractures. These patients are sometimes treated with …

Backgrounds To study the effects of supplementation of a marine omega-3 poly-unsaturated
fatty acids (n3-PUFA) formulation (Omega3Q10) in older adults with hypertension and/or …

Objective. The objective of this study is to explore the relationships of the effects of
CYP2C19 and PON1 Q192R polymorphism on the activity of clopidogrel and the risk of high …

Methods: Platelet function testing by light transmission aggregometry was performed on 65
patients with ischemic stroke who were stable on dual antiplatelet therapy (clopidogrel 75 …

Acute coronary syndrome (ACS) has become a vital disease with high mortality worldwide. A
combined antiplatelet therapy (aspirin and a P2Y12 antagonist) is commonly used to …

Currently there is an increased number of genetic tests available for disorders produced by
chromosomal or gene abnormalities. Some genetic tests are recommended by healthcare …

Background Antiplatelet therapy is a cornerstone of secondary stroke prevention, but the
responsiveness to antiplatelet medication varies among patients. Clopidogrel is a pro-drug …

Since aspirin and clopidogrel are the widely and conventionally used drugs to treat acute
myocardial infarction after percutaneous coronary intervention (PCI), it is important to …

Clopidogrel, an oral platelet P2Y12 receptor blocker, is used in the treatment of acute
coronary syndrome. Interindividual variability in treatment response and the occurrence of …